Introduction: The revision of Brazilian Regulatory Standard No. 1 (NR-1), mandating psychosocial risk management, constitutes a normative response to a documented crisis: in 2024, the INSS recorded 472,328 work absences due to mental disorders, a 68% increase over 2023, at an estimated social security cost of BRL 3 billion. However, implementation falls on a pharmaceutically fragile retail sector: between 2022 and 2024, 10.2% of pharmacies closed, with 94% of closures concentrated among independent and small establishments. Objective: To critically analyze the regulatory, economic, and institutional challenges of NR-1 implementation in Brazilian community pharmacies, proposing an operational framework grounded in Implementation Science and Lean Healthcare. Method: Scoping Review complemented by Policy Analysis, guided by the CFIR, RE-AIM, and Proctor frameworks. Results: A structural regulatory paradox was identified: NR-1 formally protects workers, but without adequate institutional support it amplifies competitive asymmetries between large chains and independent pharmacies, increases litigation risk, and may accelerate closures of essential healthcare services. The insufficient psychosocial care network, with 21.6% of eligible municipalities lacking an operational CAPS, and INSS medical examination deficiencies compound the problem. Final Considerations: The FISMO-FC Framework is proposed as an operational response to the identified regulatory paradox.